Effective January 9, 2013, M. Robert Campbell, age 43, has been appointed as Chief Financial Officer Hemagen Diagnostics Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -100.00% | -100.00% |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 15 | |
-4.62% | 12.32B | |
+8.48% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
+28.84% | 2.23B | |
-3.80% | 2.37B | |
-4.64% | 1.87B |
- Stock Market
- Equities
- HMGN Stock
- News Hemagen Diagnostics, Inc.
- Hemagen Diagnostics Inc. Appoints M. Robert Campbell as Chief Financial Officer